Marlborough has been established to achieve growth via acquisition in licensing new opportunities and forming mutually beneficial business partnerships.

The experience of the founding directors across a wide range of pharmaceutical products and markets allows us to make rapid assessments of potential opportunities.

Marlborough is prepared to look at all therapeutic areas in the prescription pharmaceutical and related markets.

The founding directors have established a range of contracts and partnerships with
companies responsible for manufacture, packaging and distribution in the UK and Europe.

Marlborough is prepared to assess divestments of individual brands and product portfolios.

Marlborough is prepared to invest in products to modernise, upgrade and meet modern standards and is prepared to invest in marketing such products.